Brandinium

Trademark search for:

NUCRYST PHARMACEUTICALS

EXPIRED USPTO USPTO

No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.

Trademark records may change over time. For the most up-to-date trademark status, domain availability, and social handle checks, run a live search.

Live search · Most up-to-date results
Also check across: EU CA AU NZ CH

USPTO Filing History

Key events recorded for this trademark application

  • 2001-11-08 — Application filed
  • 2002-01-14 — Final disposition recorded
  • 2002-07-08 — Paper received
  • 2002-07-08 — Correspondence received in law office
  • 2002-08-12 — Letter of suspension mailed
  • 2003-03-24 — Inquiry as to suspension mailed
  • 2003-08-12 — Paper received
  • 2003-08-12 — Correspondence received in law office
  • 2003-09-06 — Case file in ticrs
  • 2003-09-16 — Letter of suspension mailed
  • 2004-04-20 — Inquiry as to suspension mailed
  • 2004-10-12 — Paper received
  • 2004-10-12 — Correspondence received in law office
  • 2004-10-22 — Amendment from applicant entered
  • 2004-10-25 — Suspension letter written
  • 2004-10-26 — Letter of suspension mailed
  • 2005-01-03 — Fax received
  • 2005-01-03 — Correspondence received in law office
  • 2005-01-05 — Divisional request received
  • 2005-01-10 — Divisional processing complete
  • 2005-01-25 — Amendment from applicant entered
  • 2005-02-15 — Legal instrument examiner (lie) - correction
  • 2005-02-15 — Correspondence received in law office
  • 2005-02-15 — Amendment from applicant entered
  • 2005-02-15 — Data modification completed
  • 2005-03-07 — Approved for pub - principal register
  • 2005-03-09 — Previous allowance count withdrawn
  • 2005-03-30 — Final disposition recorded
  • 2005-03-31 — Final disposition recorded
  • 2005-05-12 — Assigned to examiner
  • 2005-05-18 — Examiners amendment -written
  • 2005-05-18 — Examiners amendment mailed
  • 2005-05-19 — Approved for pub - principal register
  • 2005-05-20 — Assigned to lie
  • 2005-05-31 — Law office publication review completed
  • 2005-05-31 — Assigned to lie
  • 2005-09-07 — Notice of publication
  • 2005-09-27 — Published for opposition
  • 2005-12-20 — Noa mailed - sou required from applicant
  • 2006-06-15 — Sou teas extension received
  • 2006-06-15 — Sou extension 1 filed
  • 2006-06-15 — Sou extension 1 granted
  • 2006-12-14 — Paper received
  • 2006-12-14 — Sou extension 2 filed
  • 2007-02-26 — Sou extension 2 granted
  • 2007-04-25 — Paper received
  • 2007-04-25 — Sou extension 3 filed
  • 2007-08-01 — Sou extension 3 granted
  • 2007-12-17 — Paper received
  • 2007-12-17 — Sou extension 4 filed
  • 2008-01-17 — Sou extension 4 granted
  • 2008-06-18 — Paper received
  • 2008-06-18 — Sou extension 5 filed
  • 2008-06-27 — Sou extension 5 granted
  • 2009-01-19 — Application abandoned
  • 2009-01-19 — Final status recorded
  • 2009-01-21 — Application abandoned

Owner Information

Nucryst Pharmaceuticals Corp.
Alberta T8L 3W4 CA
Nucryst Pharmaceuticals Corp.
Alberta T8L 3W4 CA

Correspondent

B. BRETT HEAVNER FINNEGAN HENDERSON FARABOW GARRETT
901 NEW YORK AVENUE, NW
WASHINGTON, DC 20001-4413
UNITED STATES

Filing Details

Filing Date:
2001-11-08
Status Date:
2009-01-19
Category:
Medical Apparatus
Filing Year:
2001

Disclaimer: This page is informational only and does not constitute legal advice. Trademark availability depends on jurisdiction, usage, and legal interpretation.